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Notes on Drosophila Cdi4 is a p21/p27/p57-like cyclin-dependent kinase inhibitor with specificity for cyclin 
E complexes. 
This paper describes the use of a yeast two-hybrid interaction mating assay to screen large panels of 
proteins for informative interactions. In one of our first panel screens we discovered that Drosophila cyclin 
E interacts with two other Drosophila proteins, Rux and Cdi4. This finding led to new hypotheses about 
the function of Rux and Cdi4. 
While we were characterizing Cdi4 and its interaction with cyclin E, two groups, one led by de Nooij and 
Hariharan and the other by Lane and Lehner, independently isolated mutations in a gene, decapo, that 
encodes Cdi4. Both groups presented elegant experiments demonstrating the importance of decapo in 
regulating the cell cycle during development (de Nooij et al., 1996. Cell 87, 1237-1247 [Medline]; Lane et 
al., 1997. Cell 87, 1225-1235 [Medline]). Our paper includes some data not duplicated by the work from 
de Nooij et al., or Lane et al., including in vitro kinase inhibition assays, yeast interaction assays, and our 
sequence analyses. This paper is not published. To reference data in this paper please refer to R.L. 
Finley, B. Cohen, an R. Brent, personal communication, or refer to this web site. 
Thomas and Zipursky and colleagues have studied the function of Rux, a negative regulator of the cell 
cycle in the developing eye. The function of Rux and its interaction with cyclins was further explored, and 
a model for how Rux works was published by Thomas et al. 1997, Genes & Development, 11:94-105 
[Medline]. 
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Summary 
The eukaryotic cell cycle is controlled by a network of interacting regulatory proteins. We used an 
interaction mating two-hybrid assay to identify connections within the cell cycle regulatory network in 
Drosophila. We tested interactions between Drosophila cyclins and a panel of hundreds of previously 
identified proteins. One of the connections we identified was the interaction between cyclin E and a novel 
Drosophila protein, Cdi4. Because Cdi4 was originally identified by its ability to interact with a Drosophila 
cyclin-dependent kinase, the finding that it interacts with cyclin E strengthened the notion that it functions 
in cell cycle regulation. We show that Cdi4 can inhibit cyclin E function both in a yeast assay and in vitro. 
In light of these results, our sequence analysis revealed that Cdi4 is a unique member of the p21/p27/p57 
family of Cdk inhibitors. Our results demonstrate that interaction mating assays using large informative 
panels of proteins can aid the analysis of regulatory networks by generating and constraining hypotheses 
that guide further work. 
Introduction 
Biological processes are controlled by networks of regulatory proteins. The function of individual 
members of these networks is often not clear, and new members are often being identified more rapidly 
than the functions of known members are determined. The network of proteins that controls cell division 
in metazoans illustrates this point. Cell division is controlled by numerous interacting cell cycle regulatory 
proteins. These proteins include cyclin-dependent kinases (Cdks) and cyclins (Hunter and Pines, 1994; 
Lees, 1995; Nigg, 1995; Nurse, 1994), and a number of Cdk interacting proteins (Cdis), which modify Cdk 
activity (Sherr and Roberts, 1995), or which have uncharacterized functions (Finley et al., 1996). 
In Drosophila, the G1 to S transition is controlled in several tissues by developmental regulation of Cdks 
and cyclins. For example, cyclin E expression is required for ectodermal and midgut cells in the embryo to 
enter S phase (Duronio and O'Farrell, 1995; Knoblich et al., 1994; Richardson et al., 1993; Sauer et al., 
1995). In the developing eye imaginal disc, cyclin E is expressed in clusters of cells about to enter S 
phase posterior to the morphogenetic furrow. Cyclin D is also expressed in the eye imaginal disc, but in a 
stripe at the anterior edge of the morphogenetic furrow that preceeds but does not overlap cyclin E 
expression (Finley et al., 1996; Richardson et al., 1995; Richardson et al., 1993). This pattern is 
consistent with a model in which cyclin D stimulates the transition from G1 arrest into G1 progression in 
response to external signals such as developmental cues, and cyclin E then drives cells into S phase. 
Contrary to this model, expression of cyclin D or cyclin E in some cells in the developing eye disc is not 
sufficient to drive them out of G1 (Finley et al., 1996; Richardson et al., 1995). These results have 
suggested that there are other levels of developmental control over cyclin protein function. However, few 
proteins that modulate Cdk/cyclin activity in Drosophila have been identified. 
Yeast two-hybrid systems have proven especially useful in the identification and analysis of cell cycle 
regulatory proteins (Durfee et al., 1993; Fields and Song, 1989; Finley and Brent, 1994; Gyuris et al., 
1993; Hannon et al., 1993; Harper et al., 1993). Drosophila cyclin D and cyclin J, for example, were 
originally identified in a yeast two-hybrid interactor hunt (Finley et al., 1996). Conventional yeast two-
hybrid methods, however, have not been effective to characterize cell cycle regulators and other proteins 
that are strong transcription activators. For example, Drosophila cyclin E is an unsatisfactory bait in such 
screens because it activates transcription when brought to DNA. Moreover, high level constitutive 
expression of cyclin E is toxic to yeast. Here we circumvented these problems with a scaled-up version of 
a modified two-hybrid approach, interaction mating (Finley and Brent, 1994), to identify proteins that might 
affect cyclin E activity. In this technique, test proteins fused to a transcription activation domain are 
conditionally expressed in one yeast strain. This strain is mated to a large number of different strains 
containing different LexA fusion baits, and reporter activation is assayed in the exconjugants. This 
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approach enabled us to quickly screen a panel of hundreds of previously characterized bait proteins for 
interactions with cyclin E and other Drosophila cyclins. 
Here we show that Drosophila cyclin E interacts specifically with the Drosophila Cdk interactor, Cdi4. We 
show that Cdi4 is a substrate for Cdk/cyclin E but not Cdk/cyclin D complexes in vitro, and that Cdi4 
inhibits Cdk/cyclin kinase activity. These results prompted careful sequence analysis, which indicated that 
Cdi4 belongs to the p21/p27/p57 class of cell cycle inhibitors. These and other results demonstrate the 
power of interaction mating to spark the generation of hypotheses about gene function. This ability to 
generate hypotheses will be particularly important in the analysis of the genomes of human and other 
organisms that lack manipulative genetics. 
Results 
Interaction mating reveals specific association of cyclin E with Cdi4 
We collected 550 different bait plasmids from our lab and from other investigators. These plasmids 
express fusions of LexA to a variety of well or partially characterized proteins from Drosophila, yeast, 
mammals, and other organisms. We introduced the bait plasmids into a strain containing a sensitive 
LexAop-lacZ reporter (Colas et al., 1996; Estojak et al., 1995) to construct a panel of bait strains. The 
panel was arrayed in a 96-well pattern on yeast plates and then replica-mated with a strain expressing a 
test protein such as Drosophila cyclin E fused to a transcription activation domain. We scored interaction 
by blue color after replica plating the exconjugants onto X-Gal medium. The technique is illustrated in Fig. 
1 (Experimental Procedures). 
Figure 1 
 
 Figure 1 legend: We tested several Drosophila cyclins against this panel. Fig. 1 shows a typical result, in 
which strains containing either the vector alone, or expressing activation domain fusions to Drosophila 
cyclin D or cyclin E, were mated with a set of panel members (128 different baits). Some panel members 
contain baits that activate transcription on their own (e.g., Fig. 1, position A1); we thus scored an 
interaction only when we observed blue color that depended on the cyclin. Fig. 1, for example, shows that 
the baits at positions G2, G8, and K12 interacted specifically with cyclin E. The baits at positions G2, G8, 
and K12 are Drosophila Rux, human p21CIP1/WAF1/Sdi1, and Drosophila Cdi4, respectively. Fig. 1 also 
shows that cyclin E interacted specifically with the baits at positions C2, E10, and H2. These are human 
p130, human p107, and the C-terminus of yeast Ste7, respectively. These baits did not interact with cyclin 
D (Fig. 1) or with cyclin C or cyclin J (Finley et al., 1996) (not shown). 
4 
http://dx.doi.org/10.6076/J7WD3XHS 
http://authors.fredhutch.org/1194 
 
In addition to the interactions with the Drosophila Cdks already described (Finley et al., 1996), the panel 
revealed several interactions that were predictable and some that were unexpected (Table 1). For 
example, Cyclin D interacted strongly with human Cdk6, a partner of human D cyclins (Meyerson and 
Harlow, 1994), and Cyclin E interacted with human p21CIP1/WAF1, which inhibits Cdk/cyclin activity (el-
Deiry et al., 1993; Harper et al., 1993). Cyclin E also interacted with two Rb-related proteins, p130, and 
p107, that are known to interact with cyclins (Ewen et al., 1992; Hannon et al., 1993; Lees et al., 1992). 
By contrast, Drosophila cyclin C (Lahue et al., 1991; Leopold and O'Farrell, 1991) did not interact with any 
panel members (data not shown), while Drosophila cyclin J interacted only with a Drosophila Cdk 
(DmCdc2c) and yeast Cdc28, confirming previous work (Finley et al., 1996). 
Cyclin E also interacted unexpectedly with four proteins not previously known to be cyclin interactors: 
HTLV-1 Tax protein, a transcription factor (Seiki et al., 1985); the C-terminus of the yeast Ste7 protein, a 
protein kinase involved in signal transduction (Teague et al., 1986); and two novel Drosophila proteins, 
Rux and Cdi4 (see below). These findings suggested that these four proteins may play a role in cell cycle 
regulation by directly interacting with cyclins, or alternatively that their function may be directly modulated 
by cyclins. Here we explored the possible significance to cell cycle regulation of the cyclin E interaction 
with Cdi4. Cdi4 was already a suspected cell cycle regulator because it was isolated in a hunt for proteins 
that contact one or more Drosophila Cdks (Finley et al., 1996). 
We confirmed interactions of cyclin E with Cdi4 by mating yeast that expressed activation domain-tagged 
Cdi4 with the bait panel. Cdi4 interacted with both splice variant forms of Drosophila cyclin E, type I and 
type II (Richardson et al., 1993), and with human cyclin E, which is 41% identical to Drosophila cyclin E 
(data not shown). Cdi4 also interacted with a cyclin E derivative that contains the cyclin box (residues 
193-517), a region of cyclins that contacts Cdks (Draetta, 1990; Lees and Harlow, 1993) 
Cdi4 inhibits cyclin E activity in yeast 
We used a yeast assay to test whether Cdi4 can regulate cyclin E activity. We tested whether Cdi4 could 
prevent the toxic effect of human cyclin E in yeast. In yeast, high level expression of cyclin E inhibits 
growth (see below), perhaps because it causes inappropriate activation of the yeast Cdk, Cdc28. Table 2 
shows this effect. Compared with a control plasmid, human cyclin E causes a 10-fold reduction in 
transformation efficiency. Table 2 also shows that co-transformation of the cyclin E plasmid along with a 
plasmid expressing Cdi4 from the yeast GAL1 promoter increased the transformation efficiency over 10-
fold (Table 2). This rescue depended on Cdi4 expression, as it was only observed when transformants 
were plated on galactose medium (not shown). These results suggest that the interaction of Cdi4 with 
cyclin E inhibited Cdk/cyclin E activity. 
Cdi4 is a substrate for Cdk/cyclin complexes in vitro and inhibits Cdk/cyclin kinase activity 
We further tested interaction in vitro by determining whether Cdi4 was phosphorylated by complexes 
containing cyclin E. Fig. 2a shows that Cdi4 (and Rux) fusion proteins were phosphorylated by human 
Cdk2 and cyclin A (Cdk2/cyclin A), Cdk2 and cyclin E (Cdk2/cyclin E), but not by Cdk4 and cyclin D1 
complexes (Cdk4/cyclin D), further suggesting that these interactions were functional. 
Cdi4 inhibited the kinase activity of the Cdk2/cyclin E or Cdk2/cyclin A combinations (Fig. 2b, 2c). MBP-
Cdi4 inhibited both Cdk/cyclin complexes by well over 50% (Fig 2b and 2c, lanes 4) when present at less 
than 2-fold molar excess over the histone H1 substrate (although we do not know what proportion of the 
bacterially-expressed fusion protein is active). Inhibition of kinase activity increased by over 10-fold when 
the amount of MBP-Cdi4 in the reaction was doubled (compare lanes 3 and 4 in Fig. 2b and 2c), 
suggesting that inhibition by Cdi4 may be cooperative. Cdi4 did not inhibit kinase activity of the 
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Cdk4/cyclin D1 lysates (Fig. 2d), consistent with the two hybrid and in vitro results showing that Cdi4 
interacts only weakly or not at all with D type cyclins. 
Figure 2 
  
Figure 2 legend: . Cdi4 is an in vitro substrate of Cdk/cyclins and inhibits kinase activity. a, Lysates from 
cells infected with baculovirus expressing human Cdk2 and cyclin A (lanes 1-3), human Cdk2 and cyclin 
E (lanes 4-6), mouse Cdk4 and cyclin D1 (lanes 9-12), or not infected ("mock", lanes 7 and 8) were used 
to phosphorylate bacterially expressed, affinity purified maltose binding protein (MBP) or MBP fused to 
Cdi4, or GST-pRb. Lysates were diluted to achieve approximately equal levels of phosphorylation of 
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histone H1 or pRb (not shown). b, Cdk2/cyclin E lysates were incubated with 0.2 µg of histone H1 (H1) 
and 0, 0.4, 0.8, 1.6, 3.2, 6.4 µg of MPB-Cdi4 (lanes 1-6, respectively), or 6.4 µg MBP (lane 7). Lane 8 
contains 6.4 µg MBP-Cdi4 but no H1. c, Cdk2/cyclin A lysates were incubated with 0.2 µg of histone H1 
(H1) and 0, 0.4, 0.8, 1.6, 3.2, or 6.4 µg of MPB-Cdi4 (lanes 1-6, respectively), or 6.4 µg MBP (lane 7). 
Lane 8 contains 6.4 µg MBP-Cdi4 but no H1. d, Cdk4/cyclin D1 lysates were incubated with 0.3 µg of 
GST-Rb (pRb) and 0, 0.4, 0.8, 1.6, 3.2 µg of MPB-Cdi4 (lanes 1-5, respectively).  
Having shown that Cdi4 inhibited Cdk/cyclin activity, and that it can inhibit cyclin E toxicity in yeast, we 
compared its sequence carefully to that of known Cdk inhibitors, or Ckis (Sherr and Roberts, 1995). We 
found that Cdi4 has sequence similarity with the p21/p27/p57 class of Ckis (Fig. 3). Members of this class 
include mammalian p21CIP1/WAF1/Sdi1 (here called p21) (el-Deiry et al., 1993; Harper et al., 1993; 
Noda et al., 1994; Xiong et al., 1993), p27KIP1 (here called p27) (Polyak et al., 1994), and p57KIP2 (here 
called p57) (Lee et al., 1995; Matsuoka et al., 1995), a Xenopus p27 (Su et al., 1995), and a C.elegans 
Cki with similarity to p21. Most of the similarity between these proteins lies in their amino terminal 90 
residues (see Fig. 3b). In human p21, this region interacts with Cdk/cyclin complexes and inhibits their 
kinase activity (Chen et al., 1995; Goubin and Ducommun, 1995; Luo et al., 1995; Nakanishi et al., 1995). 
This region of Cdi4 contains 10 residues found in all p21/p27/p57 family members, and an additional 3 
amino acids found in at least 6 of these Ckis. The middle of Cdi4 (from 92 to 161) has no significant 
similarity with other Ckis, but the carboxy terminus has separate regions that resemble p21 and p57. 
From residues 162-185, Cdi4 contains 7 identical and 6 similar amino acids found in a region of p21s but 
not other Ckis; in human p21, this portion of the protein interacts with PCNA (Chen et al., 1995; Luo et al., 
1995). From residues 186 to the C-terminus, Cdi4 contains a region rich in prolines and alanines, which 
includes a PAPA repeat, similar to a region found in p57s but not other Ckis (Fig. 3d) (Lee et al., 1995; 
Matsuoka et al., 1995). Combined, these results indicate that Cdi4 is a Cki that shares characteristics with 
both the p21 and p57 proteins. 
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Figure 3 
 
Figure 3 legend: a, Predicted amino acid sequence encoded by the Drosophila Cdi4 cDNA (Finley et al., 
1996). b, Alignment of first 88 residues of Cdi4 with the amino terminal portions of mouse, human, and rat 
p21, mouse and human p27 and p57, Xenopus p27, and a C.elegans p21-like protein. Shaded amino 
acids occur in at least six of the 10 Ckis. Amino acids shown below Cdi4 are found in at least 9 of the 10 
Ckis. c, Residues 162 to 185 of Cdi4 aligned with regions in the C-terminal half of mouse and human p21. 
Shaded amino acids are identical in all three proteins; boxed amino acids are conserved. d, Residues 186 
to 213 of Cdi4 aligned with three adjacent proline and alanine rich regions in the C-terminal half of human 
p57, and one in mouse p57. Alignments were made using the Wisconsin Package (Genetics Computer 
Group) PILEUP program and visual inspection. 
Discussion 
Two-hybrid systems have been enormously useful for identification of new genes, for example those 
involved in cell cycle regulation (Allen et al., 1995; Mendelsohn and Brent, 1994; Phizicky and Fields, 
1995). Extensions of these systems, such as interaction mating, have also begun to find use for charting 
genetic pathways and assessing gene function (Finley et al., 1994). Here we applied these methods on a 
larger scale to study the protein network that regulates the cell cycle in response to developmental cues 
in Drosophila. We began with cyclins, which have often been refractory to traditional two-hybrid methods 
because they activate transcription as baits and sometimes are toxic in yeast. 
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In these experiments, we expressed Drosophila cyclins conditionally and tested their ability to interact 
with a large panel of previously identified bait proteins. The baits in this panel came from our lab and from 
hundreds of other labs using the yeast two-hybrid system. The panel comprises a set enriched in proteins 
of interest to contemporary biologists; most of which are known members of one or more regulatory 
networks. Our experiments revealed four previously unsuspected interactions between Drosophila cyclin 
E and members of the panel. Although they were above the detection threshold, and conceivably 
significant, we did not pursue two of these: HTLV-1 tax and S. cerevisiae Ste7. A third, Drosophila Rux, is 
a negative regulator of cell cycle progression required for proper eye development (Thomas et al., 1994). 
Our results suggest that at least one way Rux might function is by direct interaction with cyclins (Thomas 
et al., 1997). Here we explored another interaction that seemed to make sense for cell cycle regulation, 
between cyclin E and Drosophila Cdi4. 
We have shown here that Cdi4, which was isolated because it interacts with a Drosophila Cdk, DmCdc2c, 
interacts with cyclin E and inhibits its activity. This finding prompted us to carefully compare the Cdi4 
sequence to that of other inhibitors of Cdk/cyclin activity (Ckis). We found that, although Cdi4 has low 
overall similarity to individual Ckis, it contains sequence motifs conserved in the amino termini of the 
p21/p27/p57 class of Ckis, a portion of these proteins that is thought to contact Cdks and cyclins (Chen et 
al., 1995; Lin et al., 1996; Luo et al., 1995; Nakanishi et al., 1995). It also contains separate regions at its 
C-terminus which resemble p21s and p57s, respectively. The C-terminal parts of these proteins are not 
conserved and may have different functions. The C-terminal half of p21, for example, interacts with PCNA 
and inhibits PCNA-dependent DNA replication, but the C-terminus of p57 does not (Chen et al., 1995; 
Luo et al., 1995). Whether or not Cdi4 interacts with PCNA, our results clearly indicate that Cdi4 is a p21 
and p57-like Drosophila Cki that could inhibit cell cycle progression by blocking kinase activity. 
p21/p27/p57 Ckis have a higher affinity for Cdk/cyclin complexes than for monomeric Cdks (Sherr and 
Roberts, 1995). This is consistent with the idea that these Ckis make contacts both with Cdks and with 
cyclins (Lin et al., 1996). Our results are consistent with this idea: they suggest that Cdi4 makes individual 
binary contacts, with an affinity detectable with our two hybrid system, both with a Drosophila Cdk and 
cyclin E. Moreover, our results show that Cdi4 specifically inhibits Cdk/cyclin A or Cdk/cyclin E 
complexes, and not of Cdks complexed with cyclin C, cyclin J, or cyclin D, suggesting that the different 
affinities of Cdi4 for the different cyclins are decisive in determining which complexes it inhibits. The 
affinity of Cdi4 for cyclin E, which is required for the G1 to S phase transition (Knoblich et al., 1994), 
suggests that Cdi4 may inhibit entry into S, perhaps in response to developmental signals. The spurious 
rounds of S phase observed in dacapo Drosophila mutants, and the recent finding that these mutants 
bear lesions in the Cdi4 coding region, are consistent with this idea (I. Hariharan and C. Lehner, personal 
communication). 
Our results clearly demonstrate that interaction mating against panels of characterized proteins can 
provide insights into the function of both interacting partners. These insights come from the ability of this 
technique to suggest easily testable hypotheses about the interacting partners. The power of the 
technique grows as the panel grows: currently, it consists of more than 700 proteins, each of which has 
been at least somewhat characterized. The emergence of this technique is timely, since the need to 
assign function to genes, particularly those with no sequence similarity to known genes, and those from 
organisms without well developed genetics, is great. Our results with Cdi4 and Rux demonstrate that 
interaction mating followed by ad hoc experiments to verify the conclusions may provide a quick route to 
this task. 
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Methods 
Yeast strains and manipulations 
Saccharomyces cerevisiae yeast strains used were RFY206 (MATa his3delta200 leu2-3 lys2delta201 
ura3-52 trp1 delta::hisG) (Finley and Brent, 1994), EGY48 (MAT alpha his3 ura3 trp1 LYS2 leu2::3Lexop-
LEU2) (Estojak et al., 1995), EGY40 (MAT alpha his3 ura3 trp1 leu2 LYS2) (E. Golemis and R. Brent, 
unpublished), and 3c1Ax (MATa bar1 trp1 leu2 ura3 ade1 cyh2 his2 delta cln1 delta cln2 delta cln3 
[pLEU2-CYH2-CLN3]) (provided by J. Roberts and F. Cross). Yeast were grown using standard 
microbiological techniques and media (Ausubel et al., 1987-1997; Guthrie and Fink, 1991). Media 
designations are as follows: YPD is YP (yeast extract plus peptone) medium with 2% glucose. Minimal 
dropout media are designated by the component that is left out (e.g. -ura -his -trp -leu medium lacks 
uracil, histidine, tryptophan, and leucine). Minimal media contained either 2% glucose (Glu) or 2% 
galactose plus 1% raffinose (Gal). X-Gal minimal dropout plates contained X-Gal and phosphate buffer at 
pH 7.0. DNA was introduced into yeast by LiOAc-mediated transformation as described (Gietz et al., 
1992). 
Plasmids 
Most bait plasmids are derived from pLEX(202+PL) (Ruden et al., 1991) or pEG202 (Estojak et al., 1995), 
which both contain the HIS3 gene, 2µm origin of replication, and the ADH1 promoter driving expression of 
fusion proteins with amino acids 1 to 202 of LexA at their amino termini. A small number of the bait 
plasmids are derived from either pNLex (provided by B. Vogelstien) which is derived from pLEX(202+PL) 
but encodes LexA with a nuclear localization signal at its C-terminus prior to the fusion protein, or pNLexA 
(provided by I. York) which encode fusions with LexA at their C-terminal rather than N-terminal end. Bait 
plasmids that expressed variants of Drosophila cyclin E were derived from pGILDA (D. Shaywitz and C. 
Kaiser, personal communication) in which the LexA fusion protein is expressed from the GAL1 promoter 
instead of the ADH1 promoter, allowing transient expression of toxic proteins. Bait plasmids for which 
interactions are reported here are as follows: pRF202-Cdi4 is pEG202 cut with EcoRI and XhoI with an 
inserted a 876 bp MunI-XhoI fragment of the original Cdi4 cDNA (Finley et al., 1996) generated by 
polymerase chain reaction (PCR) with the 5’ MunI site introduced in the 5’ primer 
(CAATTGCAAGGCAGCCCGGCGGTGAGTCG) and the 3’ XhoI site from the original cDNA downstream 
of the stop codon; this plasmid encodes the entire 255 amino acid Cdi4 protein shown in Fig. 4a with an 
additional glutamine (Q) and leucine (L) encoded by the MunI site; pKZ202-Rux is pEG202 cut with 
BamHI, filled-in with Klenow, then cut with XhoI, with an inserted 1.22 kb fragment encoding amino acid 2 
to the C-terminus of Rux; pRF202-DmcycE(193-517) is pEG202 cut with EcoRI and XhoI with an inserted 
980 bp PCR-generated EcoRI-XhoI fragment encoding amino acids 193-517 of Drosophila cyclin E type I 
(numbering system of Richardson et al. (Richardson et al., 1993)). Plasmids encoding LexA fusions to 
human Cdk6 and human p21CIP1/WAF1/SDI1 have been described (Reymond and Brent, 1995). Other 
bait plasmids encoded human p130 or p107 (provided by C. Sardet and R. Weinberg), amino acids 322-
1139 of human p130 (provided by A. Bannister and T. Kouzarides), HTLV-1 Tax (provided by K. 
Clemens), and the C-terminal 344 amino acids of S. cerevisiae Ste7 (provided by B. Satterberg and E. 
Elion). The 2 µm URA3 lacZ reporter pSH18-34 containing four LexA operators upstream of a GAL1-lacZ 
fusion, pSH18-34, has been described. Derivatives of pJG4-5 (Gyuris et al., 1993) that expressed 
activation domain-tagged fusions to Drosophila cyclin D (p4-5-Cdi3), cyclin J (p4-5-Cdi5), and Cdi4 (p4-5-
Cdi4) were originally isolated in two-hybrid hunts for Drosophila Cdk interactors (Finley et al., 1996). The 
pJG4-5 derivative that expressed activation domain-tagged Drosophila cyclin E (p4-5-Cdi7ÆN) encodes 
from amino acid 38 to the C-terminus of Drosophila cyclin E type II (numbering system of Richardson et 
al. (Richardson et al., 1993). p4-5-Rux was made by inserting the EcoRI fragment from pKZLex-Rux 
encoding amino acids 2 to the C-terminus of Rux into the EcoRI site of pJG4-5. pHC21 (H. Chertkov, J. 
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Gyuris, R.Brent, unpublished) is a 2µm URA3 plasmid containing an ADH1 promoter and terminator 
expression cassette. pHC21-HsCycE (H. Chertkov, J. Gyuris, R.Brent, unpublished) expresses full-length 
human cyclin E from the ADH1 promoter. pRF4-6o is a 2µm TRP1 plasmid made by inserting an EcoRI-
XhoI ended 36 bp oligonucleotide containing multiple unique restriction sites into pJG4-6 (J. Gyuris and 
R. Brent, unpublished) cut with EcoRI and XhoI; the unique restriction sites reside between the yeast 
GAL1 promoter and ADH1 terminator, just downstream of an ATG and coding region for the 7 amino acid 
heamaglutinin epitope tag (HA). Coding regions for Rux, Cdi4, or Cdi11 (Finley et al., 1996) were inserted 
into the unique sites of pRF4-6o to allow galactose-dependent expression of these proteins with an HA 
tag at their amino termini. Vectors for expressing fusions of maltose binding protein (MBP) to Rux or Cdi4 
were made by inserting the EcoRI fragment from pKZ-Rux or a MunI-XhoI PCR fragment of Cdi4 (see 
above) into the EcoRI cut or EcoRI/XhoI cut pMAL-c2 (New England Biolabs). 
Panel of baits 
We collected 550 bait plasmids that expressed LexA fusion proteins. About 150 of the plasmids were 
made in our own labs and the remainder was kindly donated by other labs using the two-hybrid system. A 
complete list of the bait plasmids in the panel is available on request or can be obtained at 
http://www.xanadu.mgh.harvard.edu/. Bait strains were created by transforming yeast strain RFY206 with 
the lacZ reporter pSH18-34 and individual bait plasmids. Bait strains were selected and maintained on 
glucose minimal medium lacking uracil and histidine (-u-h Glu), and were stored frozen by resuspending 
fresh cultures in 1:1 -u-h Glucose medium:glycerol solution (Finley and Brent, 1996). The 550 bait strains 
were arrayed in a 96-well configuration on 150 mm -u-h glucose plates (~96 bait strains/plate). Bait 
strains were transferred to new plates or to liquid cultures from saturated 4 ml -u-h Glu cultures in 96-well 
cluster tubes using a 96 prong device. 
Interaction mating 
Interaction mating assays were performed essentially as previously described (Finley and Brent, 1994; 
Finley and Brent, 1995; Finley and Brent, 1996). The entire panel of 550 bait strains was arrayed on six 
150 mm plates with up to 96 different strains on each plate. "Prey" strains were EGY48 containing pJG4-5 
or derivatives of pJG4-5 that expressed individual cyclins or other proteins with a transcription activation 
domain fused to their amino terminal end. Prey strains were grown in -w Glu liquid medium to saturation 
and transferred to 150 mm plates in a 96-well configuration using a 96 prong device. Bait and prey strain 
plates were grown for two days at 30oC and then replica mated by pressing both plates to the same 
replica velvet and lifting the impression with a single 150 mm YPD plates. The YPD plates were incubated 
at 30oC for one day then replica plated to two X-Gal indicator that lack uracil, tryptophan, and histidine so 
that only diploids could grow, and that contain either 2% glucose (Glu) or 2% galactose (plus 1% raffinose 
to aid growth) to induce expression of the activation domain-tagged protein. An interaction was scored 
when a diploid strain turned bluer on the Gal X-Gal plate than on the Glu X-Gal, and that was also bluer in 
the presence of an activation domain-tagged protein than with the vector alone. 
Yeast assays 
In separate experiments yeast strain EGY40 or 3c1Ax were co-transformed using the lithium acetate 
method (Gietz et al., 1992) with 0.5 µg each of a Cen/Ars URA3 plasmid and a TRP1 plasmid and plated 
at various dilutions on glucose medium lacking uracil and tryptophan. The URA3 plasmid was either 
pHC21 (H. Chertkov and R.B., unpublished), or pHC21-HsCycE that expressed human cyclin E from the 
yeast ADH1 promoter. The TRP1 plasmid was pRF4-6o, pRF4-6-Rux, pRF4-6-Cdi4, or pRF4-6-Cdi11. 
Transformant colonies were counted after 2 days. 
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Kinase assays 
in vitro kinase assays were performed using lysates from baculovirus infected Sf9 cells essentially as 
described (Kato et al., 1993). Sf9 cells were co-infected with recombinant baculoviruses expressing 
human His6-tagged cyclin E and HA-tagged Cdk2 (provided by D. Morgan), HA-tagged Cdk2 and GST-
tagged cyclin A (provided by H. Piwinica-Wroms), or mouse Cdk4 and cyclin D1 (provided by C. Sherr), or 
no Cdk and cyclin (mock) at an MOI of 10 for each virus. Cells were grown at 27oC in TMN-FH plus 10% 
fetal bovine serum (FBS) in 100 ml spinner flasks for 40 hours, then harvested by centrifugation, washed 
once in PBS, and resuspended in cold 500 µl lysis buffer (50 mM HEPES pH7.5, 10 mM MgCl2, 1 mM 
DTT, 10 mM ß-glycerophosphate, 0.1 mM each PMSF, NaF, Na orthovanadate, and 5 µg/ml each 
aprotinin and leupeptin) . The lysates were incubated on ice for 1 hour, then clear by centrifugation at 
10,000 x g for 20 min. Aliquots were frozen at -80oC. Kinase assays were performed in 20 µl of lysis 
buffer using 2 µl of lysate diluted 100-fold (Cdk2/cyclin E and Cdk4/cyclin D1) or 50-fold (Cdk2/cyclin A) in 
the presence of 25 µM ATP and 2.5 µCi 32P-gammaATP (3000 Ci/mmol), and either 0.2 µg histone H1, 
0.3 µg bacterially expressed and affinity purified GST-Rb (provided by A. Reymond), or bacterially 
expressed and affinity purified fusions of maltose binding protein (MBP) to Cdi4 or Rux. Kinase assays 
were incubated at 25oC for 20 min. , stopped by adding 10 µl Laemmli sample buffer, and analyzed on 10 
% PAGE-SDS gels. 
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Table 1. Summary of cyclin interactions with members of the panel of baits. 
  
Bait Cyc E Cyc D Vect. 
Hs Cdk6 - +++ - 
Hs 
p21CIP1/WAF1/Sdi1 
+++ - - 
Hs p130 ++ - - 
Hs p107 ++ - - 
HTLV-1 tax ++ - - 
Sc Ste7 (C-terminus) ++ - - 
Dm Rux +++ - - 
Dm Cdi4 +++ + - 
 
Interaction mating was performed as described in Experimental Procedures and shown in Fig. 1. Level of 
interaction as determined by blue color on X-Gal indicator plates: +++ indicates dark blue, ++ light blue, + 
very light blue, and - white. For baits that activate transcription on their own, the amount of increase in 
blue color in the presence of the cyclin relative to its absence is reported 
________________________________________ 
 
Table 2. Rux and Cdi4 overcome the toxic effect of Cyclin E overexpression in yeast. 
  
  pHC21 pHC21-
HsCycE 
pRF4-6o 152 ± 12 16 ± 4 
pRF4-6-Rux 82 ± 5 174 ± 18 
pRF4-6-Cdi4 94 ± 2 150 ± 7 
pRF4-6-Cdi11 166 ± 13 20 ± 4 
 
Numbers indicate transformants/0.1 µg of pHC21 or pRFHC21-HsCycE in double transformations of 
yeast strain EGY40 with 0.5 µg of pHC21 or pHC21-HsCycE and 0.2 µg of pRF4-6 or derivatives 
expressing Rux, Cdi4, or Cdi11. Transformations were plated on selective medium containing galactose. 
The average of two experiments are shown with the difference between the two as the variance. Similar 
results were obtained with yeast strain 3c1Ax (data not shown). 
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